Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean... by Dae-Ho Choi, MD, Miso Kim, MD, PhD, Young Saing Kim, MD, PhD, Keon Uk Park, MD, PhD, Jang Ho Cho, MD, PhD, Hongsik Kim, MD, PhD, Ki Hyeong Lee, MD, PhD, Heejoon Ahn, MD, PhD, Il-Hwan Kim, MD, PhD, Kyung-Hee Lee, MD, PhD, Gyeong-Won Lee, MD, PhD, Seong Yoon Yi, MD, PhD, Beung chul Ahn, MD, PhD, Min-Young Lee, MD, PhD, Hyun Ae Jung, MD, PhD, Sehhoon Park, MD, PhD, Jong-Mu Sun, MD, PhD, Jin Seok Ahn, MD, PhD, Se-Hoon Lee, MD, PhD, Myung-Ju Ahn, MD, PhD

Get full text